big article in fin review

the article appeared on page 26 of the week end review. Its all about exercise and that sporting physiotherapist recommending that people take heart tests before starting exercise. This is the sort of growth area that lends itself to this sort of product. Aged care and general tests are also strong areas of growth. The key to these tests is that the dr make money and they get the machine for free to conduct the tests. Medicare is also on the band wagon providing the punter with the ability to get some money back and it shows us that preventative care is being recognised as a serious area of medicine. Australia has 30,000 doctors, so sit back and watch the numbers on this. The recent announcement on entering the corporate market is great as they tend to need tests for insurance and they pay a lot more for the tests. The revenues from this is a numbers game with each machine dropping more money in to the company. Research this if you like, it looks good to me as the machine is proven and the roll out has seriously started now. Each machine does tests everyday and each test is money for the company. Its not rocket science. You dont need many machines before the recurring income just gets bigger. Its a re-rate story to me thats why i bought them and it has far less risk that a lot of the biotech sector. good luck.